期刊论文、会议论文

Clinical research of schistosomiasis liver fibrosis treatment with Kangxianling prescription

中文

湖南中医药大学学报

1674-070X

2013

33

1

102-107

2012年朱文峰学术思想研讨会暨中医诊断师资班30周年纪念大会

2012年朱文峰学术思想研讨会暨中医诊断师资班30周年纪念大会论文集

2012-10-01

长沙

中华中医药学会

10.3969/j.issn.1674-070X.2013.01.029.0102.06

国家自然科学基金(No.39190929)

本校为第一机构

目的:探讨郭振球教授抗纤灵方辨证治疗血吸虫病肝纤维化的疗效及机理。方法:将血吸虫病肝纤维化患者辨证分为抗纤灵Ⅰ方组(气虚血瘀证型)、抗纤灵Ⅱ方组(气滞血瘀证型)、西医常规治疗组(两证型混合)3组,治疗40天后,比较观察临床症征及疗效、肝脾B超及疗效、胶原代谢和血浆纤溶酶等指标的改变。结果:治疗40天后,①抗纤灵两方对血吸虫病肝纤维化常见的10项症征症征减轻明显,临床症征积分值分别减少7.76分和6

Objective To study the curative effect and mechanism of Kangxianling prescription of the professor GUO Zhen-qiu on schistosomiasis liver fibrosis treatment based on syn- drome differentiation. Methods Based on syndrome differentiation, schistosomiasis patients with liver fibrosis were divided into 3 groups including Kangxianling prescription I group （blood stasis with qi deficiency type）, Kangxianling prescriptionII group （blood stasis with qi stagnation type） and west- ern medicine convention treatment group （two type mixing）. After trea...